FDCDDQ
DAWN

Federation des caisses Desjardins du Quebec’s Day One Biopharmaceuticals DAWN Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.4K Hold
2,024
– – ﹤0.01% 1901
2025
Q4 		$18.9K Hold
2,024
– – ﹤0.01% 2067
2025
Q3 		$14.3K Hold
2,024
– – ﹤0.01% 2133
2025
Q2 		$13.2K Hold
2,024
– – ﹤0.01% 1939
2025
Q1 		$16.1K Hold
2,024
– – ﹤0.01% 1803
2024
Q4 		$25.6K Sell
2,024
-800
-28% -$11.1K ﹤0.01% 1595
2024
Q3 		$39.3K Hold
2,824
– – ﹤0.01% 1469
2024
Q2 		$38.9K Hold
2,824
– – ﹤0.01% 1448
2024
Q1 		$46.7K Hold
2,824
– – ﹤0.01% 1426
2023
Q4 		$41.2K Buy
2,824
+1,059
+60% +$12.8K ﹤0.01% 1379
2023
Q3 		$21.7K Buy
1,765
+270
+18% +$3.52K ﹤0.01% 1546
2023
Q2 		$17.9K Hold
1,495
– – ﹤0.01% 1608
2023
Q1 		$20K Buy
1,495
+1,070
+252% +$20.9K ﹤0.01% 1571
2022
Q4 		$9.15K Buy
+425
New +$8.72K ﹤0.01% 1902

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's DAWN Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Day One Biopharmaceuticals (DAWN) position steady in Q1 2026 at 2,024 shares worth $43.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1901.

Federation des caisses Desjardins du Quebec first reported a position in DAWN in Q4 2022 and has held it in 14 quarters since. The position peaked at $46.7K in Q1 2024. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 2,024 shares of Day One Biopharmaceuticals worth $43.4K as of Q1 2026.
  • Federation des caisses Desjardins du Quebec left its Day One Biopharmaceuticals share count unchanged in Q1 2026.
  • Day One Biopharmaceuticals made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #1901 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Day One Biopharmaceuticals in Q4 2022 and has held it in 14 quarters since.
  • Federation des caisses Desjardins du Quebec's Day One Biopharmaceuticals position peaked at $46.7K in Q1 2024.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.